CD4 and neoplasm: We and others previously reported that host preconditioning with CTX or TBI allows adoptively transferred tumor-specific CD4+ T cells to differentiate into polyfunctional effector cells characterized by their ability to concomitantly express multiple effector molecules including CD40L, IFNγ, IL-2, TNFα and granzyme B11,25–27.